BR9306399A - Composição farmacéutica para uso no tratamento de glaucoma - Google Patents

Composição farmacéutica para uso no tratamento de glaucoma

Info

Publication number
BR9306399A
BR9306399A BR9306399A BR9306399A BR9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A BR 9306399 A BR9306399 A BR 9306399A
Authority
BR
Brazil
Prior art keywords
glaucoma
remedy
treatment
pharmaceutical composition
methoxyphenoxy
Prior art date
Application number
BR9306399A
Other languages
English (en)
Inventor
Takaaki Deguchi
Yoshifumi Ikejiri
Takahiro Ogawa
Katsuhiro Inada
Original Assignee
Senju Pharma Co
Yamanouchi Pharma Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co, Yamanouchi Pharma Co Ltd filed Critical Senju Pharma Co
Publication of BR9306399A publication Critical patent/BR9306399A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/18—Sulfonamides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
BR9306399A 1992-05-22 1993-05-19 Composição farmacéutica para uso no tratamento de glaucoma BR9306399A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP13082892 1992-05-22
PCT/JP1993/000654 WO1993024121A1 (fr) 1992-05-22 1993-05-19 Medicament pour le glaucome

Publications (1)

Publication Number Publication Date
BR9306399A true BR9306399A (pt) 1998-09-15

Family

ID=15043659

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9306399A BR9306399A (pt) 1992-05-22 1993-05-19 Composição farmacéutica para uso no tratamento de glaucoma

Country Status (14)

Country Link
US (1) US5663205A (pt)
EP (1) EP0642789B1 (pt)
KR (1) KR100253515B1 (pt)
CN (1) CN1080849A (pt)
AT (1) ATE185070T1 (pt)
BG (1) BG62325B1 (pt)
BR (1) BR9306399A (pt)
CA (1) CA2136321A1 (pt)
DE (1) DE69326610T2 (pt)
ES (1) ES2137260T3 (pt)
HU (1) HUT71123A (pt)
RU (1) RU2102069C1 (pt)
TW (1) TW219930B (pt)
WO (1) WO1993024121A1 (pt)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2737494B1 (fr) * 1995-08-04 1997-08-29 Synthelabo Derives de benzenesulfonamide, leur preparation et leur application en therapeutique
ID19891A (id) * 1996-08-02 1998-08-20 Senju Pharma Co Komposisi gangguan peredaran anti-okular
US6379688B2 (en) 1997-02-28 2002-04-30 Senju Pharmaceutical Co., Ltd. Preservative for emulsion and emulsion containing same
US6036946A (en) * 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light
US6146664A (en) * 1998-07-10 2000-11-14 Shaklee Corporation Stable topical ascorbic acid compositions
JP2002523475A (ja) * 1998-09-02 2002-07-30 アラーガン・セイルズ・インコーポレイテッド 防腐したシクロデキストリン含有組成物
US7867186B2 (en) 2002-04-08 2011-01-11 Glaukos Corporation Devices and methods for treatment of ocular disorders
US7708711B2 (en) 2000-04-14 2010-05-04 Glaukos Corporation Ocular implant with therapeutic agents and methods thereof
US7431710B2 (en) 2002-04-08 2008-10-07 Glaukos Corporation Ocular implants with anchors and methods thereof
AU2002258754B2 (en) 2001-04-07 2006-08-17 Glaukos Corporation Glaucoma stent and methods thereof for glaucoma treatment
US7678065B2 (en) 2001-05-02 2010-03-16 Glaukos Corporation Implant with intraocular pressure sensor for glaucoma treatment
WO2002089699A2 (en) 2001-05-03 2002-11-14 Glaukos Corporation Medical device and methods of use for glaucoma treatment
US7331984B2 (en) 2001-08-28 2008-02-19 Glaukos Corporation Glaucoma stent for treating glaucoma and methods of use
US7163543B2 (en) * 2001-11-08 2007-01-16 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US7951155B2 (en) 2002-03-15 2011-05-31 Glaukos Corporation Combined treatment for cataract and glaucoma treatment
US9301875B2 (en) 2002-04-08 2016-04-05 Glaukos Corporation Ocular disorder treatment implants with multiple opening
AU2003280812A1 (en) * 2002-11-18 2004-06-15 Santen Pharmaceutical Co., Ltd. REMEDY FOR GLAUCOMA COMPRISING Rho KINASE INHIBITOR AND Beta-BLOCKER
ZA200902453B (en) * 2006-10-31 2010-07-28 Alcon Res Ltd PAI-1 binding modulators for the treatment of ocular disorders
AU2007319383A1 (en) 2006-11-10 2008-05-22 Glaukos Corporation Uveoscleral shunt and methods for implanting same
CZ2009190A3 (cs) * 2009-03-30 2010-10-13 Ústav experimentální medicíny AV CR, v.v.i Zpusob merení lokální toxicity látek a zarízení k jeho provádení
US10206813B2 (en) 2009-05-18 2019-02-19 Dose Medical Corporation Implants with controlled drug delivery features and methods of using same
JP5937004B2 (ja) 2009-05-18 2016-06-22 ドーズ メディカル コーポレーションＤｏｓｅ Ｍｅｄｉｃａｌ Ｃｏｒｐｏｒａｔｉｏｎ 薬剤溶出眼内インプラント
US12478503B2 (en) 2009-05-18 2025-11-25 Glaukos Corporation Implants with controlled drug delivery features and methods of using same
US9668915B2 (en) 2010-11-24 2017-06-06 Dose Medical Corporation Drug eluting ocular implant
EP4193907B1 (en) 2011-09-13 2026-04-15 Glaukos Corporation Intraocular physiological sensor
JP6523958B2 (ja) * 2012-09-28 2019-06-05 タフツ・ユニバーシティ ウリジン二リン酸誘導体、プロドラッグ、組成物およびそれらの使用
US9730638B2 (en) 2013-03-13 2017-08-15 Glaukos Corporation Intraocular physiological sensor
WO2017040853A1 (en) 2015-09-02 2017-03-09 Glaukos Corporation Drug delivery implants with bi-directional delivery capacity
WO2017053885A1 (en) 2015-09-25 2017-03-30 Glaukos Corporation Punctal implants with controlled drug delivery features and methods of using same
US11318043B2 (en) 2016-04-20 2022-05-03 Dose Medical Corporation Bioresorbable ocular drug delivery device
JP6917103B1 (ja) * 2021-05-17 2021-08-11 株式会社坪田ラボ 近視抑制用点眼剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3306820A (en) * 1966-03-18 1967-02-28 Barnes Hind Pharm Inc Ophthalmic composition containing an anesthetic and fluorescein sodium
US4127674A (en) * 1977-03-21 1978-11-28 Allergan Pharmaceuticals, Inc. Method of treatment for glaucoma
JPS5495544A (en) * 1977-12-23 1979-07-28 Yamanouchi Pharmaceut Co Ltd Phenylethanolamine derivative and its preparation
CA1147342A (en) * 1977-10-12 1983-05-31 Kazuo Imai Process of producing novel phenylethanolamine derivatives
JPS5746946A (en) * 1980-07-09 1982-03-17 Sandoz Ag 3-aminopropoxyphenyl derivative, manufacture and medicine containing same
DE3125870C2 (de) * 1980-07-09 1994-09-15 William John Louis 3-Aminopropoxyphenyl Derivate, ihre Herstellung und sie enthaltende Arzneimittel
IE51421B1 (en) * 1980-08-01 1986-12-24 Smith & Nephew Ass Ophthalmic compositions containing triamterene
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
FR2640969B1 (pt) * 1988-12-23 1991-11-22 Midy Spa
FR2642755B1 (pt) * 1989-02-07 1993-11-05 Sanofi
WO1994001096A1 (en) * 1992-07-02 1994-01-20 Telor Ophthalmic Pharmaceuticals, Inc. Methods and products for treating presbyopia

Also Published As

Publication number Publication date
HU9403350D0 (en) 1995-02-28
RU94046143A (ru) 1996-09-27
ES2137260T3 (es) 1999-12-16
DE69326610T2 (de) 2000-06-08
WO1993024121A1 (fr) 1993-12-09
RU2102069C1 (ru) 1998-01-20
ATE185070T1 (de) 1999-10-15
EP0642789B1 (en) 1999-09-29
HUT71123A (en) 1995-11-28
CN1080849A (zh) 1994-01-19
US5663205A (en) 1997-09-02
BG62325B1 (bg) 1999-08-31
CA2136321A1 (en) 1993-12-09
TW219930B (pt) 1994-02-01
EP0642789A4 (pt) 1995-03-29
KR100253515B1 (ko) 2000-05-01
EP0642789A1 (en) 1995-03-15
BG99213A (bg) 1995-08-28
DE69326610D1 (de) 1999-11-04

Similar Documents

Publication Publication Date Title
ES2137260T3 (es) Composicion farmaceutica para uso en el tratamiento del glaucoma.
NO930817L (no) Imidazolderivater med bifenylsulfonylurea- eller bifenylsulfonyluretan-sidekjeder, fremgangsmaate for deres fremstilling og deres anvendelse
ATE170510T1 (de) 3-(hydroxybenzylidenyl)-indolin-2-one und diese enthaltende arzneimittel
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
DE69206876D1 (de) Nukleosidanalogen enthaltende Antiviren-Zubereitungen
ZA934997B (en) Use of 2-(N-(2-aminoethyl)amino)acetic acid derivatives
DE68902301D1 (de) Diarylverbindungen als antiatherosklerotische mittel.
DE69226370D1 (de) Parathyroidhormon enthaltene emulsion zur nasalen verabreichung
DK0630252T3 (da) Farmaceutisk præparat på basis af rhamnolipid mod dermatologiske sygdomme
ES2103440T3 (es) Nuevas amidas y sulfonamidas naftalenicas, procedimiento de preparacion y composiciones farmaceuticas que las contienen.
FI943931A0 (fi) Indolijohdannaisia steroidi-5alfa-reduktaasin inhibiittoreina
FI101882B1 (fi) Herbisidiset [[(1,3,5-triatsin-2-yyli) aminokarbonyyli]aminosulfonyyli]bentsoehappoesterit, niitä sisältävä valmiste ja niiden käyttö
ATE108775T1 (de) N-phenyl-piperidyl-4-amine und diese enthaltende arzneimittel.
NO950177D0 (no) Farmakologisk aktive erivater
DE69118204D1 (de) Bekämpfung von parasitischen nematoden
EP0999209A4 (en) 2-sulfamoylbenzoic DERIVATIVES
ATE56967T1 (de) Amidderivate.
EP0666253A4 (en) N-T-BUTYLANILINE ANALOG CONNECTIONS AS LIPID LEVEL LOWERERS.
ES2076054T3 (es) Nuevas amino-alquil-cromonas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NO973122D0 (no) Middel for å minske okular spenning
KR930016417A (ko) 피롤릴벤조디아제핀온
IT1313583B1 (it) Derivati 2-amminotetralinici per la terapia del glaucoma.
ES8105146A1 (es) Un procedimiento para la preparacion de una solucion liquidainyectable de una sulfonamida
SE8402709D0 (sv) Stabiliserade flytande n-substituerade karbamatpreparat till anvendning som herbicider
RU98109064A (ru) Глазные пленки

Legal Events

Date Code Title Description
EG Technical examination (opinion): publication of technical examination (opinion)
FC Decision: refusal
FC Decision: refusal